You can support your methylation pathways with dietary interventions and supplements
While Agamrees label does not carry a boxed warning, it does list precautions regarding alterations in endocrine, cardiovascular and renal function, immunosuppression and ophthalmic side effects, among others

Food & Drug Administration (2021) Insulin resistance, Cleveland Clinic (2021) The potential role of incretin-based therapies for polycystic ovary syndrome: A narrative review of the current evidence, Sage Journals (2021) Impact of obesity on infertility in women, Journal of the Turkish-German Gynecological Association (2015) Semaglutide treatment of excessive body weight in obese PCOS patients unresponsive to lifestyle programs, Journal of Clinical Medicine (2023) Semaglutide vs metformin in polycystic ovary syndrome (PCOS), Clinicaltrials.gov (2024) Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes, Diabetes Car e (2012) Liraglutide for weight management: a critical review of the evidence, Obesity Science and Practice (2017) Polycystic ovary syndrome: Common questions and answers, American Family Physician (2023) Insulin resistance in polycystic ovarian syndrome, Cureus ( 2022) Hirsutism, Mayo Clinic (2021) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

GLP-1 medications work by mimicking the bodys own hormone, helping to reduce appetite and slow the rate at which the stomach empties
Some people are highly sensitive to GLP-1 medications and see results at the lowest possible dose
These financial factors make it vital for interested Medicare enrollees to thoroughly weigh the pros and cons of using the Bridge Program to access these medications